NCT00468806View on ClinicalTrials.gov

Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.

PHASE1CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Healthy Subjects

Interventions

DRUG

GSK598809, using [11C]-(+)-PHNO

Trial Locations (1)

M5T 1R8

GSK Investigational Site, Toronto

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00468806 - Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males. | Biotech Hunter | Biotech Hunter